Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
NEW YORK , March 4, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit s
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE:GSK) between Febru
GSK plc (GSK) TD Cowen 45th Annual Health Care Conference (Transcript)
09:08pm, Monday, 03'rd Mar 2025
GSK plc (NYSE:GSK ) TD Cowen 45th Annual Health Care Conference March 3, 2024 9:50 AM ET Company Participants Luke Miels - Chief Commercial Officer Conference Call Participants Steve Scala - TD Cowen
Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline - GSK
07:45pm, Monday, 03'rd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of GSK plc (NYSE: GSK) between Febr
Shareholders of GSK plc Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights – GSK
01:20pm, Monday, 03'rd Mar 2025
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK).
Shareholders That Lost Money on GSK plc (GSK) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
01:15pm, Monday, 03'rd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the
NEW YORK , March 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc ("GSK" or the "Company") (NYSE: GSK). Such investors are advised to contact
GSK's Twice-Yearly Depemokimab Reduces Nasal Polyp Size, Goes Under FDA Review
11:54am, Monday, 03'rd Mar 2025
On Monday, the Food and Drug Administration (FDA) accepted for review GSK plc's GSK marketing application for depemokimab in two indications.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK Lawsuit - GSK
10:45am, Monday, 03'rd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
10:07am, Monday, 03'rd Mar 2025
NEW YORK , March 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February
Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline - GSK
07:25am, Monday, 03'rd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the
NEW YORK CITY, NY / ACCESS Newswire / March 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GSK pl
NEW YORK , March 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period listed
